Prostate International

Papers
(The TQCC of Prostate International is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
A review of social determinants of prostate cancer risk, stage, and survival58
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort26
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer24
Prostate diseases and microbiome in the prostate, gut, and urine24
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer19
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review15
Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy14
Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia14
Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Tur14
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study13
Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies13
Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study12
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?12
Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer11
A systematic review of outcomes after thermal and nonthermal partial prostate ablation11
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy11
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients11
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study10
Rebiopsy rate after transperineal or transrectal prostate biopsy10
Impact of positive surgical margin on biochemical recurrence in localized prostate cancer10
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis10
Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group9
Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry9
Laparoscopic radical prostatectomy versus robot-assisted radical prostatectomy: comparison of oncological outcomes at a single center9
Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rect8
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea8
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures8
Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology8
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship8
RNA-seq profile of African American men with a clinically localized prostate cancer8
Risk factors associated with pain in fusion prostate biopsy8
Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer7
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description7
Measurement of autophagy flux in benign prostatic hyperplasia in vitro7
A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer7
Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride7
Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes7
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy7
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer7
0.016774892807007